Eli Lilly briefly crossed the $1 trillion market cap threshold, the first drug maker to ever reach that milestone.
(THE CONVERSATION) The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with pharmaceutical giants, announced Nov. 6, 2025, will reduce the ...
Purchases of food and beverage products high in carbohydrates and sugar are decreasing among GLP-1 users, who are “actively ...
Orforglipron, a new daily GLP-1 pill, could replace weight-loss injections like Wegovy and Ozempic. Studies show it helps ...
Medically reviewed by Patricia Mikula, PharmD Some supplements may support or increase the effects of GLP-1 medications. They ...
Your gut changes on GLP-1s — but you don’t have to feel miserable. These 23 probiotics smooth digestion, calm bloating, and ...
Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...
Serena Williams has endorsed GLP-1 medications, raising questions regarding their stigma and performance-enhancing potential for athletes.
GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San ...
U.S. researchers are beginning to identify clinical characteristics that distinguish “super responders” to GLP-1 weight-loss ...
Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...
At the 2025 Society for Neuroscience meeting, scientists discussed the adverse side effects of GLP-1 agonists and new ...